comparemela.com
Home
Live Updates
Israels Sol-Gel signs Canadian licensing deal for Twyneo, Epsolay (NASDAQ:SLGL) : comparemela.com
Israel's Sol-Gel signs Canadian licensing deal for Twyneo, Epsolay (NASDAQ:SLGL)
Israel's Sol-Gel (SLGL) has signed an exclusive licensing deal with Searchlight Pharma for the Canadian commercialization rights to its dermatology products Twyneo and Eposolay.
Related Keywords
Canada
,
Israel
,
Canadian
,
,
Antibiotics In Laboratory
,
Screen Showing Virus Analysis Software User Interface
,
Research Scientist
,
Female Research Scientist
,
Bioengineer Working
,
Personal Computer
,
Screen Showing Virus Analysis Software User
,
Scientists Developing Vaccine
,
Searchlight Pharma
,
comparemela.com © 2020. All Rights Reserved.